Product Information
QC ASPIRIN 325 MG TABLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0159 per EA under NDC 83324006601. Its NADAC has been published 73 times since Feb 5, 2025.
Strength
325 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324006601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
9/3/2024
Pharmacological Classes
Price Statistics
The NADAC for QC ASPIRIN 325 MG TABLET has been published 73 times since Feb 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0159 per EA |
|---|---|
| All-time high | $0.0160 (Mar 12, 2025) |
| All-time low | $0.0153 (Jul 23, 2025) |
| 52-week high | $0.0160 |
| 52-week low | $0.0153 |
| Median price | $0.0158 |
| Average price | $0.0158 |
| Largest weekly change | -4.4% (Jul 23, 2025) |
| Weeks tracked | 73 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC ASPIRIN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QC ASPIRIN 325 MG TABLET, manufactured by Chain Drug Marketing Association, is $0.0159 per EA (NDC 83324006601), effective Jun 24, 2026.
How has the price of QC ASPIRIN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for QC ASPIRIN 325 MG TABLET has held within roughly two percent of its current level. It has been tracked across 73 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for QC ASPIRIN 325 MG TABLET?
Since Feb 5, 2025, the NADAC for QC ASPIRIN 325 MG TABLET has ranged from a low of $0.0153 (Jul 23, 2025) to a high of $0.0160 (Mar 12, 2025), with a median of $0.0158 per EA.
Are there cheaper alternatives to QC ASPIRIN 325 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC ASPIRIN 325 MG TABLET, is $0.0121 per EA — about 24% below QC ASPIRIN 325 MG TABLET.
Who manufactures QC ASPIRIN 325 MG TABLET?
QC ASPIRIN 325 MG TABLET (NDC 83324006601) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification